Urologix Revenue 2010-2015 | ULGX
Urologix revenue from 2010 to 2015. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Urologix Annual Revenue (Millions of US $) |
|
|---|---|
| 2014 | $14 |
| 2013 | $17 |
| 2012 | $17 |
| 2011 | $13 |
| 2010 | $15 |
| 2009 | $13 |
| Urologix Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2015-03-31 | $3 |
| 2014-12-31 | $3 |
| 2014-09-30 | $3 |
| 2014-06-30 | $3 |
| 2014-03-31 | $3 |
| 2013-12-31 | $4 |
| 2013-09-30 | $4 |
| 2013-06-30 | $4 |
| 2013-03-31 | $4 |
| 2012-12-31 | $4 |
| 2012-09-30 | $4 |
| 2012-06-30 | $4 |
| 2012-03-31 | $5 |
| 2011-12-31 | $5 |
| 2011-09-30 | $3 |
| 2011-06-30 | $3 |
| 2011-03-31 | $3 |
| 2010-12-31 | $3 |
| 2010-09-30 | $3 |
| 2010-06-30 | $3 |
| 2010-03-31 | $4 |
| 2009-12-31 | $4 |
| 2009-09-30 | $4 |
| 2009-06-30 | $3 |
| 2009-03-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave, Targis and Prostatron control units and the Cooled ThermoCath, Targis and Prostaprobe catheter families. Additionally, Urologix is currently developing CoolMax, its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe, effective, lasting relief of the symptoms of benign prostatic hyperplasia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.775B | 24.06 |
| Stryker (SYK) | United States | $123.999B | 29.70 |
| Medtronic (MDT) | Ireland | $108.563B | 15.37 |
| Boston Scientific (BSX) | United States | $106.438B | 33.90 |
| EssilorLuxottica (ESLOY) | France | $97.377B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.685B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.625B | 27.47 |
| ResMed (RMD) | United States | $31.870B | 29.92 |
| Terumo (TRUMY) | Japan | $26.117B | 36.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.962B | 19.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.803B | 15.84 |
| Baxter (BAX) | United States | $18.605B | 13.23 |
| Insulet (PODD) | United States | $12.352B | 64.85 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.041B | 23.96 |
| BellRing Brands (BRBR) | United States | $7.489B | 35.08 |
| Lantheus Holdings (LNTH) | United States | $5.234B | 13.04 |
| Haemonetics (HAE) | United States | $4.844B | 24.77 |
| Perrigo (PRGO) | Ireland | $4.530B | 12.96 |
| GN Store Nord (GNNDY) | Denmark | $4.368B | 24.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.43 |
| Envista Holdings (NVST) | United States | $3.276B | 13.52 |
| QuidelOrtho (QDEL) | United States | $2.903B | 10.54 |
| Green Thumb Industries (GTBIF) | United States | $2.634B | 83.47 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| TG Therapeutics (TGTX) | United States | $2.552B | 71.78 |
| ICU Medical (ICUI) | United States | $2.454B | 18.31 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.265B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.886B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.786B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.683B | 49.34 |
| InMode (INMD) | Israel | $1.566B | 8.33 |
| Owens & Minor (OMI) | United States | $1.470B | 12.81 |
| National Vision Holdings (EYE) | United States | $1.431B | 44.56 |
| AdaptHealth (AHCO) | United States | $1.409B | 10.60 |
| Warby Parker (WRBY) | United States | $1.268B | 0.00 |
| AtriCure (ATRC) | United States | $1.052B | 0.00 |
| MacroGenics (MGNX) | United States | $1.024B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.985B | 0.00 |
| Evolus (EOLS) | United States | $0.838B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.822B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.666B | 14.43 |
| Quanterix (QTRX) | United States | $0.643B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.03 |
| Jin Medical (ZJYL) | China | $0.560B | 0.00 |
| Valneva SE (VALN) | France | $0.522B | 0.00 |
| PetIQ (PETQ) | United States | $0.519B | 19.40 |
| TerrAscend (TSNDF) | Canada | $0.501B | 0.00 |
| Surmodics (SRDX) | United States | $0.463B | 29.00 |
| Biote (BTMD) | United States | $0.452B | 4.30 |
| ZimVie (ZIMV) | United States | $0.431B | 26.37 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Aurora Cannabis (ACB) | Canada | $0.362B | 0.00 |
| Zynex (ZYXI) | United States | $0.341B | 46.70 |
| Cerus (CERS) | United States | $0.331B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.319B | 31.61 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.257B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.42 |
| Veru (VERU) | United States | $0.240B | 0.00 |
| Omeros (OMER) | United States | $0.213B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.202B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.167B | 0.00 |
| InterCure (INCR) | Israel | $0.165B | 27.85 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 71.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 20.44 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 9.57 |
| MariMed (MRMD) | United States | $0.109B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 0.00 |
| Brainsway (BWAY) | Israel | $0.096B | 0.00 |
| Chimerix (CMRX) | United States | $0.090B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.067B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.87 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Bright Green (BGXX) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.50 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |